# Trump Reclassifies State-Licensed Medical Cannabis, but It's Not Legal Just Yet
The Trump administration has moved to reclassify state-licensed medical cannabis, signaling a potential shift in federal drug policy. The reclassification does not immediately legalize cannabis at the federal level, however. The change reflects growing recognition of medical cannabis use across states where it remains legal under state law.
Currently, cannabis sits in Schedule I under the Controlled Substances Act, the same category as heroin and LSD. This classification means the federal government considers it to have no accepted medical use. Many states, however, have approved medical cannabis programs. The reclassification effort aims to bridge this gap between state and federal law.
What the reclassification actually accomplishes remains unclear. It could lower cannabis to Schedule II, which would acknowledge medical potential while maintaining federal restrictions. This would allow researchers to conduct more extensive studies, something difficult under Schedule I rules. It would not automatically permit dispensaries to operate or make cannabis available without a prescription in most places.
State-licensed medical cannabis programs already operate in 38 states plus Washington D.C. Patients in these states can access cannabis for conditions like chronic pain, epilepsy, and cancer-related nausea. Federal reclassification could ease banking access for dispensaries and allow doctors to prescribe cannabis without legal risk, though state laws would still govern actual availability.
The reclassification process requires action beyond executive order. The Drug Enforcement Administration, the Food and Drug Administration, and Congress all play roles in how cannabis gets classified. A Schedule II move would need substantial evidence of medical benefit and potential for abuse.
Patients and providers should not assume immediate changes to access or legality. State laws remain the primary framework governing medical cannabis use. Anyone considering cannabis for a medical condition should consult their healthcare provider about state regulations and interactions with other medications.